1030PEvaluation of dose intensification of cytarabine in postremission therapy in older AML patients within the prospective phase II AMLSG 06-04 study L. Häcker,M. Tassara,P. Brossart,G. Held,H.A. Horst,M. Ringhoffer,C-H Köhne,S. Kremers,A. Raghavachar,G. Wulf,H. Kirchen,D. Nachbaur,M. Wattad,A. Benner,D. Weber,V.I. Gaidzik,P. Paschka,K. Döhner,H. Döhner,R. SchlenkANNALS OF ONCOLOGY（2017）引用 0|浏览48暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
